1. Home
  2. BEAT vs CTM Comparison

BEAT vs CTM Comparison

Compare BEAT & CTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAT
  • CTM
  • Stock Information
  • Founded
  • BEAT 2015
  • CTM 2019
  • Country
  • BEAT United States
  • CTM United States
  • Employees
  • BEAT N/A
  • CTM N/A
  • Industry
  • BEAT Retail: Computer Software & Peripheral Equipment
  • CTM EDP Services
  • Sector
  • BEAT Technology
  • CTM Technology
  • Exchange
  • BEAT Nasdaq
  • CTM Nasdaq
  • Market Cap
  • BEAT 65.4M
  • CTM 54.7M
  • IPO Year
  • BEAT 2021
  • CTM N/A
  • Fundamental
  • Price
  • BEAT $2.00
  • CTM $1.05
  • Analyst Decision
  • BEAT Buy
  • CTM
  • Analyst Count
  • BEAT 1
  • CTM 0
  • Target Price
  • BEAT $8.00
  • CTM N/A
  • AVG Volume (30 Days)
  • BEAT 57.4K
  • CTM 4.1M
  • Earning Date
  • BEAT 03-13-2025
  • CTM 05-14-2025
  • Dividend Yield
  • BEAT N/A
  • CTM N/A
  • EPS Growth
  • BEAT N/A
  • CTM N/A
  • EPS
  • BEAT N/A
  • CTM N/A
  • Revenue
  • BEAT N/A
  • CTM $44,764,852.00
  • Revenue This Year
  • BEAT N/A
  • CTM N/A
  • Revenue Next Year
  • BEAT N/A
  • CTM N/A
  • P/E Ratio
  • BEAT N/A
  • CTM N/A
  • Revenue Growth
  • BEAT N/A
  • CTM N/A
  • 52 Week Low
  • BEAT $1.70
  • CTM $0.12
  • 52 Week High
  • BEAT $3.48
  • CTM $2.83
  • Technical
  • Relative Strength Index (RSI)
  • BEAT 46.64
  • CTM 46.41
  • Support Level
  • BEAT $1.85
  • CTM $0.98
  • Resistance Level
  • BEAT $2.03
  • CTM $1.49
  • Average True Range (ATR)
  • BEAT 0.11
  • CTM 0.13
  • MACD
  • BEAT 0.00
  • CTM -0.03
  • Stochastic Oscillator
  • BEAT 51.35
  • CTM 20.00

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

About CTM Castellum Inc.

Castellum Inc is engaged in providing information technology services. The company provides financial services, healthcare, and other users of large data applications with services that include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and MBSE. In addition to constantly innovating and enhancing organic capabilities, Castellum is acquiring technology companies in the areas of cybersecurity, information technology, electronic warfare, information warfare, and information operations with businesses in the defense, federal, civilian, and commercial markets.

Share on Social Networks: